Ratings by Oppenheimer (Mark Breindenbach)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2021 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2021 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2020 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details |
